SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CEPHEID
(NQNM:CPHD Last Sale: 38.21 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (CPHD : $38.21)
$2,214 million Market Cap at September 12, 2013
Employs 470.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
904 Caribbean Drive Research Report Earnings Snapshot - Last 01/29/19
Sunnyvale, CA 94089 Fact Sheet
Phone: (408) 541-4191 Financial Statements
Fax: (408) 541-4192 Peer Comparison
Annual Reports

Thomas Gutshall, Chmn., John L. Bishop, CEO, John R. Sluis, CFO
Develops, manufactures and markets microfluidic systems that for use in biological testing. IPO at $6 June 20, 2000. Raised $30 million, selling 5 million shares, 20% of the outstanding. Lead Manager: Warburg Dillon Read LLC.
Historical Charts    Technical Analysis
No Historical Data available for CPHD

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CPHD $38.21 $ 0 $37.72 $38.4399 203,495 $28.12 $40.7 57,933
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $2,213,620

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex